{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:40:58Z","timestamp":1794638458812,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01-AI125097"],"award-info":[{"award-number":["R01-AI125097"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21-AI157864"],"award-info":[{"award-number":["R21-AI157864"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1-AI126619"],"award-info":[{"award-number":["UM1-AI126619"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA016086"],"award-info":[{"award-number":["P30-CA016086"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["75N910D00024\/HHSN261201500003I"],"award-info":[{"award-number":["75N910D00024\/HHSN261201500003I"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01127"],"award-info":[{"award-number":["PI19\/01127"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/01796"],"award-info":[{"award-number":["PI22\/01796"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-57260-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:23:39Z","timestamp":1751358219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dual role of circulating and mucosal V\u03b41 T cells in the control of and contribution to persistent HIV-1 infection"],"prefix":"10.1038","volume":"16","author":[{"given":"Brendan T.","family":"Mann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Clohosey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayley","family":"Langlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Chitrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Moreno-Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Vitalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Anne","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-0055","authenticated-orcid":false,"given":"Claire","family":"Deleage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9029-8389","authenticated-orcid":false,"given":"Marc","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2349-263X","authenticated-orcid":false,"given":"Natalia","family":"Soriano-Sarabia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"57260_CR1","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi, D. et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295\u20131300 (1997).","journal-title":"Science"},{"key":"57260_CR2","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1073\/pnas.0800050105","volume":"105","author":"S Palmer","year":"2008","unstructured":"Palmer, S. et al. Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA 105, 3879\u20133884 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57260_CR3","doi-asserted-by":"publisher","first-page":"15109","DOI":"10.1073\/pnas.96.26.15109","volume":"96","author":"RT Davey Jr.","year":"1999","unstructured":"Davey, R. T. Jr. et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl Acad. Sci. USA 96, 15109\u201315114 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"57260_CR4","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41564-023-01349-3","volume":"8","author":"RT Veenhuis","year":"2023","unstructured":"Veenhuis, R. T. et al. Monocyte-derived macrophages contain persistent latent HIV reservoirs. Nat. Microbiol. 8, 833\u2013844 (2023).","journal-title":"Nat. Microbiol."},{"key":"57260_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41564-018-0335-z","volume":"4","author":"Y Ganor","year":"2019","unstructured":"Ganor, Y. et al. HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy. Nat. Microbiol. 4, 633\u2013644 (2019).","journal-title":"Nat. Microbiol."},{"key":"57260_CR6","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/infdis\/jit308","volume":"208","author":"SA Yukl","year":"2013","unstructured":"Yukl, S. A. et al. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J. Infect. Dis. 208, 1212\u20131220 (2013).","journal-title":"J. Infect. Dis."},{"key":"57260_CR7","doi-asserted-by":"publisher","first-page":"e1005201","DOI":"10.1371\/journal.ppat.1005201","volume":"11","author":"N Soriano-Sarabia","year":"2015","unstructured":"Soriano-Sarabia, N. et al. Peripheral Vgamma9Vdelta2 T cells are a novel reservoir of latent HIV infection. PLoS Pathog. 11, e1005201 (2015).","journal-title":"PLoS Pathog."},{"key":"57260_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41577-020-00452-4","volume":"21","author":"JC Ribot","year":"2021","unstructured":"Ribot, J. C., Lopes, N. & Silva-Santos, B. gammadelta T cells in tissue physiology and surveillance. Nat. Rev. Immunol. 21, 221\u2013232 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"57260_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1148988","volume":"14","author":"M Sanz","year":"2023","unstructured":"Sanz, M. et al. Deep characterization of human gammadelta T cell subsets defines shared and lineage-specific traits. Front Immunol. 14, 1148988 (2023).","journal-title":"Front Immunol."},{"key":"57260_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","volume":"167","author":"R Di Marco Barros","year":"2016","unstructured":"Di Marco Barros, R. et al. Epithelia use butyrophilin-like molecules to shape organ-specific gammadelta T cell compartments. Cell 167, 203\u2013218.e217 (2016).","journal-title":"Cell"},{"key":"57260_CR11","doi-asserted-by":"publisher","unstructured":"Mikulak, J. et al. NKp46-expressing human gut-resident intraepithelial Vdelta1 T cell subpopulation exhibits high antitumor activity against colorectal cancer. JCI Insight 4, https:\/\/doi.org\/10.1172\/jci.insight.125884 (2019).","DOI":"10.1172\/jci.insight.125884"},{"key":"57260_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.it.2018.03.003","volume":"39","author":"MS Davey","year":"2018","unstructured":"Davey, M. S., Willcox, C. R., Baker, A. T., Hunter, S. & Willcox, B. E. Recasting human Vdelta1 lymphocytes in an adaptive role. Trends Immunol. 39, 446\u2013459 (2018).","journal-title":"Trends Immunol."},{"key":"57260_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04076-0","volume":"9","author":"MS Davey","year":"2018","unstructured":"Davey, M. S. et al. The human Vdelta2(+) T-cell compartment comprises distinct innate-like Vgamma9(+) and adaptive Vgamma9(-) subsets. Nat. Commun. 9, 1760 (2018).","journal-title":"Nat. Commun."},{"key":"57260_CR14","first-page":"206","volume":"75","author":"B Autran","year":"1989","unstructured":"Autran, B. et al. T cell receptor gamma\/delta+ lymphocyte subsets during HIV infection. Clin. Exp. Immunol. 75, 206\u2013210 (1989).","journal-title":"Clin. Exp. Immunol."},{"key":"57260_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/08892220360473934","volume":"19","author":"PJ Enders","year":"2003","unstructured":"Enders, P. J. et al. HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. AIDS Res Hum. Retroviruses 19, 21\u201329 (2003).","journal-title":"AIDS Res Hum. Retroviruses"},{"key":"57260_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/infdis\/165.5.917","volume":"165","author":"A De Maria","year":"1992","unstructured":"De Maria, A. et al. Selective increase of a subset of T cell receptor gamma delta T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection. J. Infect. Dis. 165, 917\u2013919 (1992).","journal-title":"J. Infect. Dis."},{"key":"57260_CR17","doi-asserted-by":"publisher","first-page":"10456","DOI":"10.1128\/JVI.77.19.10456-10467.2003","volume":"77","author":"MA Poles","year":"2003","unstructured":"Poles, M. A. et al. Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy. J. Virol. 77, 10456\u201310467 (2003).","journal-title":"J. Virol."},{"key":"57260_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34576-4","volume":"8","author":"GS Olson","year":"2018","unstructured":"Olson, G. S. et al. Increased frequency of systemic pro-inflammatory Vdelta1(+) gammadelta T cells in HIV elite controllers correlates with gut viral load. Sci. Rep. 8, 16471 (2018).","journal-title":"Sci. Rep."},{"key":"57260_CR19","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1016\/S2352-3018(22)00302-2","volume":"10","author":"N Climent","year":"2023","unstructured":"Climent, N. et al. Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Lancet HIV 10, e42\u2013e51 (2023).","journal-title":"Lancet HIV"},{"key":"57260_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/QAD.0b013e3282f46e7c","volume":"22","author":"H Fausther-Bovendo","year":"2008","unstructured":"Fausther-Bovendo, H. et al. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells. Aids 22, 217\u2013226 (2008).","journal-title":"Aids"},{"key":"57260_CR21","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1182\/blood-2011-11-390153","volume":"119","author":"K Hudspeth","year":"2012","unstructured":"Hudspeth, K. et al. Engagement of NKp30 on Vdelta1 T cells induces the production of CCL3, CCL4, and CCL5 and suppresses HIV-1 replication. Blood 119, 4013\u20134016 (2012).","journal-title":"Blood"},{"key":"57260_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF03401668","volume":"3","author":"M Wallace","year":"1997","unstructured":"Wallace, M. et al. Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections. Mol. Med. 3, 60\u201371 (1997).","journal-title":"Mol. Med"},{"key":"57260_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/viro.2002.1759","volume":"305","author":"S Imlach","year":"2003","unstructured":"Imlach, S., Leen, C., Bell, J. E. & Simmonds, P. Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo. Virology 305, 415\u2013427 (2003).","journal-title":"Virology"},{"key":"57260_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/QAD.0000000000002434","volume":"34","author":"KS James","year":"2020","unstructured":"James, K. S. et al. Measuring the contribution of gammadelta T cells to the persistent HIV reservoir. AIDS 34, 363\u2013371 (2020).","journal-title":"AIDS"},{"key":"57260_CR25","doi-asserted-by":"publisher","unstructured":"Pihl, R. M. F. et al. Distinct subsets of Vdelta1 effector and Vdelta2 gammadelta T cells shift in frequency and are linked to plasma inflammatory markers during ART-suppressed HIV infection. J. Infect. Dis. https:\/\/doi.org\/10.1093\/infdis\/jiae091 (2024).","DOI":"10.1093\/infdis\/jiae091"},{"key":"57260_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey, M. S. et al. Clonal selection in the human Vdelta1 T cell repertoire indicates gammadelta TCR-dependent adaptive immune surveillance. Nat. Commun. 8, 14760 (2017).","journal-title":"Nat. Commun."},{"key":"57260_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110858","volume":"39","author":"JL McMurray","year":"2022","unstructured":"McMurray, J. L. et al. Transcriptional profiling of human Vdelta1 T cells reveals a pathogen-driven adaptive differentiation program. Cell Rep. 39, 110858 (2022).","journal-title":"Cell Rep."},{"key":"57260_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1486","volume":"13","author":"KR Field","year":"2024","unstructured":"Field, K. R., Wragg, K. M., Kent, S. J., Lee, W. S. & Juno, J. A. gammadelta T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression. Clin. Transl. Immunol. 13, e1486 (2024).","journal-title":"Clin. Transl. Immunol."},{"key":"57260_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1219250","volume":"14","author":"M Sanz","year":"2023","unstructured":"Sanz, M. et al. Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1. Front Immunol. 14, 1219250 (2023).","journal-title":"Front Immunol."},{"key":"57260_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.666991","volume":"12","author":"Y Xu","year":"2021","unstructured":"Xu, Y. et al. Reliable estimation of CD8 T cell inhibition of in vitro HIV-1 replication. Front. Immunol. 12, 666991 (2021).","journal-title":"Front. Immunol."},{"key":"57260_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.virol.2006.06.017","volume":"353","author":"EJ Wherry","year":"2006","unstructured":"Wherry, E. J. et al. HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory. Virology 353, 366\u2013373 (2006).","journal-title":"Virology"},{"key":"57260_CR32","doi-asserted-by":"publisher","first-page":"969","DOI":"10.4049\/jimmunol.1002099","volume":"186","author":"R Grenningloh","year":"2011","unstructured":"Grenningloh, R. et al. Ets-1 maintains IL-7 receptor expression in peripheral T cells. J. Immunol. 186, 969\u2013976 (2011).","journal-title":"J. Immunol."},{"key":"57260_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9346","volume":"8","author":"J Nah","year":"2022","unstructured":"Nah, J. & Seong, R. H. Kruppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells. Sci. Adv. 8, eadc9346 (2022).","journal-title":"Sci. Adv."},{"key":"57260_CR34","doi-asserted-by":"publisher","unstructured":"Garrido, C. et al. gammadelta T cells: an immunotherapeutic approach for HIV cure strategies. JCI Insight 3, https:\/\/doi.org\/10.1172\/jci.insight.120121 (2018).","DOI":"10.1172\/jci.insight.120121"},{"key":"57260_CR35","doi-asserted-by":"publisher","unstructured":"Garrido, C. et al. Interleukin-15-stimulated natural killer cells clear HIV-1-infected cells following latency reversal ex vivo. J. Virol. 92, https:\/\/doi.org\/10.1128\/JVI.00235-18 (2018).","DOI":"10.1128\/JVI.00235-18"},{"key":"57260_CR36","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1172\/JCI80566","volume":"126","author":"RB Jones","year":"2016","unstructured":"Jones, R. B. & Walker, B. D. HIV-specific CD8(+) T cells and HIV eradication. J. Clin. Invest. 126, 455\u2013463 (2016).","journal-title":"J. Clin. Invest."},{"key":"57260_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41591-021-01651-9","volume":"28","author":"JS Miller","year":"2022","unstructured":"Miller, J. S. et al. Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial. Nat. Med. 28, 392\u2013400 (2022).","journal-title":"Nat. Med."},{"key":"57260_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1084\/jem.180.1.183","volume":"180","author":"Y Chowers","year":"1994","unstructured":"Chowers, Y., Holtmeier, W., Harwood, J., Morzycka-Wroblewska, E. & Kagnoff, M. F. The V delta 1 T cell receptor repertoire in human small intestine and colon. J. Exp. Med. 180, 183\u2013190 (1994).","journal-title":"J. Exp. Med."},{"key":"57260_CR39","doi-asserted-by":"publisher","first-page":"e0129771","DOI":"10.1371\/journal.pone.0129771","volume":"10","author":"E Cimini","year":"2015","unstructured":"Cimini, E. et al. Primary and chronic HIV infection differently modulates mucosal Vdelta1 and Vdelta2 T-cells differentiation profile and effector functions. PLoS One 10, e0129771 (2015).","journal-title":"PLoS One"},{"key":"57260_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.20411\/pai.v1i1.100","volume":"1","author":"C Deleage","year":"2016","unstructured":"Deleage, C. et al. Defining HIV and SIV reservoirs in lymphoid tissues. Pathog. Immun. 1, 68\u2013106 (2016).","journal-title":"Pathog. Immun."},{"key":"57260_CR41","doi-asserted-by":"publisher","first-page":"14070","DOI":"10.1128\/JVI.01900-14","volume":"88","author":"N Soriano-Sarabia","year":"2014","unstructured":"Soriano-Sarabia, N. et al. Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells. J. Virol. 88, 14070\u201314077 (2014).","journal-title":"J. Virol."},{"key":"57260_CR42","doi-asserted-by":"publisher","unstructured":"Jimenez-Leon, M. R. et al. Vedolizumab and ART in recent HIV-1 infection unveil the role of alpha4beta7 in reservoir size. JCI Insight, https:\/\/doi.org\/10.1172\/jci.insight.182312 (2024).","DOI":"10.1172\/jci.insight.182312"},{"key":"57260_CR43","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1128\/jvi.70.9.6044-6053.1996","volume":"70","author":"BK Chen","year":"1996","unstructured":"Chen, B. K., Gandhi, R. T. & Baltimore, D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70, 6044\u20136053 (1996).","journal-title":"J. Virol."},{"key":"57260_CR44","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/ni.3198","volume":"16","author":"M Sellars","year":"2015","unstructured":"Sellars, M. et al. Regulation of DNA methylation dictates Cd4 expression during the development of helper and cytotoxic T cell lineages. Nat. Immunol. 16, 746\u2013754 (2015).","journal-title":"Nat. Immunol."},{"key":"57260_CR45","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout, P. & Hayday, A. Six-of-the-best: unique contributions of gammadelta T cells to immunology. Nat. Rev. Immunol. 13, 88\u2013100 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"57260_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade3525","volume":"8","author":"R Roy Chowdhury","year":"2023","unstructured":"Roy Chowdhury, R. et al. NK-like CD8(+) gammadelta T cells are expanded in persistent Mycobacterium tuberculosis infection. Sci. Immunol. 8, eade3525 (2023).","journal-title":"Sci. Immunol."},{"key":"57260_CR47","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1182\/blood-2010-05-283549","volume":"116","author":"LD Harris","year":"2010","unstructured":"Harris, L. D. et al. Mechanisms underlying gammadelta T-cell subset perturbations in SIV-infected Asian rhesus macaques. Blood 116, 4148\u20134157 (2010).","journal-title":"Blood"},{"key":"57260_CR48","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","volume":"103","author":"A Poggi","year":"2004","unstructured":"Poggi, A. et al. Migration of V delta 1 and V delta 2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 103, 2205\u20132213 (2004).","journal-title":"Blood"},{"key":"57260_CR49","doi-asserted-by":"publisher","unstructured":"Sumaria, N. et al. Perinatal thymic-derived CD8alphabeta-expressing gammadelta T cells are innate IFN-gamma producers that expand in IL-7R-STAT5B-driven neoplasms. Nat. Immunol. https:\/\/doi.org\/10.1038\/s41590-024-01855-4 (2024).","DOI":"10.1038\/s41590-024-01855-4"},{"key":"57260_CR50","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1365-2249.2006.03022.x","volume":"143","author":"JH Colle","year":"2006","unstructured":"Colle, J. H. et al. CD127 expression and regulation are altered in the memory CD8 T cells of HIV-infected patients-reversal by highly active anti-retroviral therapy (HAART). Clin. Exp. Immunol. 143, 398\u2013403 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"57260_CR51","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.3389\/fimmu.2018.02783","volume":"9","author":"AC Belkina","year":"2018","unstructured":"Belkina, A. C. et al. Multivariate computational analysis of gamma delta T Cell inhibitory receptor signatures reveals the divergence of healthy and ART-suppressed HIV+ aging. Front. Immunol. 9, 2783 (2018).","journal-title":"Front. Immunol."},{"key":"57260_CR52","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s43018-023-00690-0","volume":"5","author":"D Davies","year":"2024","unstructured":"Davies, D. et al. PD-1 defines a distinct, functional, tissue-adapted state in Vdelta1(+) T cells with implications for cancer immunotherapy. Nat. Cancer 5, 420\u2013432 (2024).","journal-title":"Nat. Cancer"},{"key":"57260_CR53","doi-asserted-by":"publisher","unstructured":"Deseke, M. et al. A CMV-induced adaptive human Vdelta1+ gammadelta T cell clone recognizes HLA-DR. J. Exp. Med. 219, https:\/\/doi.org\/10.1084\/jem.20212525 (2022).","DOI":"10.1084\/jem.20212525"},{"key":"57260_CR54","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41586-023-06482-x","volume":"621","author":"MR Mamedov","year":"2023","unstructured":"Mamedov, M. R. et al. CRISPR screens decode cancer cell pathways that trigger gammadelta T cell detection. Nature 621, 188\u2013195 (2023).","journal-title":"Nature"},{"key":"57260_CR55","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.4049\/jimmunol.160.9.4322","volume":"160","author":"VE Garc\u00eda","year":"1998","unstructured":"Garc\u00eda, V. E. et al. IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens. J. Immunol. 160, 4322\u20134329 (1998).","journal-title":"J. Immunol."},{"key":"57260_CR56","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1086\/590112","volume":"198","author":"J Estes","year":"2008","unstructured":"Estes, J. et al. Collagen deposition limits immune reconstitution in the gut. J. Infect. Dis. 198, 456\u2013464 (2008).","journal-title":"J. Infect. Dis."},{"key":"57260_CR57","doi-asserted-by":"publisher","unstructured":"Asowata, O. E. et al. Irreversible depletion of intestinal CD4+ T cells is associated with T cell activation during chronic HIV infection. JCI Insight 6, https:\/\/doi.org\/10.1172\/jci.insight.146162 (2021).","DOI":"10.1172\/jci.insight.146162"},{"key":"57260_CR58","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41564-021-00948-2","volume":"6","author":"PH Papotto","year":"2021","unstructured":"Papotto, P. H., Yilmaz, B. & Silva-Santos, B. Crosstalk between gammadelta T cells and the microbiota. Nat. Microbiol. 6, 1110\u20131117 (2021).","journal-title":"Nat. Microbiol."},{"key":"57260_CR59","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1084\/jem.181.4.1303","volume":"181","author":"P Lusso","year":"1995","unstructured":"Lusso, P., Garzino-Demo, A., Crowley, R. W. & Malnati, M. S. Infection of gamma\/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection. J. Exp. Med. 181, 1303\u20131310 (1995).","journal-title":"J. Exp. Med."},{"key":"57260_CR60","doi-asserted-by":"publisher","first-page":"e0167215","DOI":"10.1371\/journal.pone.0167215","volume":"11","author":"AN Shatrova","year":"2016","unstructured":"Shatrova, A. N. et al. Time-dependent regulation of IL-2R alpha-chain (CD25) expression by TCR signal strength and IL-2-induced STAT5 signaling in activated human blood T lymphocytes. PLoS One 11, e0167215 (2016).","journal-title":"PLoS One"},{"key":"57260_CR61","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.humimm.2010.06.014","volume":"71","author":"C Cairo","year":"2010","unstructured":"Cairo, C. et al. Impact of age, gender, and race on circulating gammadelta T cells. Hum. Immunol. 71, 968\u2013975 (2010).","journal-title":"Hum. Immunol."},{"key":"57260_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48985-9","volume":"15","author":"GQ Lee","year":"2024","unstructured":"Lee, G. Q. et al. HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy. Nat. Commun. 15, 5480 (2024).","journal-title":"Nat. Commun."},{"key":"57260_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20442-3","volume":"12","author":"NN Kinloch","year":"2021","unstructured":"Kinloch, N. N. et al. HIV-1 diversity considerations in the application of the intact proviral DNA assay (IPDA). Nat. Commun. 12, 165 (2021).","journal-title":"Nat. Commun."},{"key":"57260_CR64","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner, K. M. et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566, 120\u2013125 (2019).","journal-title":"Nature"},{"key":"57260_CR65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho, Y. C. et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155, 540\u2013551 (2013).","journal-title":"Cell"},{"key":"57260_CR66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1365-2249.2007.03388.x","volume":"149","author":"N Fujishima","year":"2007","unstructured":"Fujishima, N. et al. Skewed T cell receptor repertoire of Vdelta1(+) gammadelta T lymphocytes after human allogeneic haematopoietic stem cell transplantation and the potential role for Epstein-Barr virus-infected B cells in clonal restriction. Clin. Exp. Immunol. 149, 70\u201379 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"57260_CR67","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cyto.a.24350","volume":"101","author":"TM Ashhurst","year":"2022","unstructured":"Ashhurst, T. M. et al. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre. Cytom. A 101, 237\u2013253 (2022).","journal-title":"Cytom. A"},{"key":"57260_CR68","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636\u2013645 (2015).","journal-title":"Cytom. A"},{"key":"57260_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv123","volume":"2","author":"DI Rosenbloom","year":"2015","unstructured":"Rosenbloom, D. I. et al. Designing and interpreting limiting dilution assays: general principles and applications to the latent reservoir for human immunodeficiency virus-1. Open Forum Infect. Dis. 2, ofv123 (2015).","journal-title":"Open Forum Infect. Dis."},{"key":"57260_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"57260_CR71","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1093\/nar\/25.12.2532","volume":"25","author":"Z Xiong","year":"1997","unstructured":"Xiong, Z. & Laird, P. W. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25, 2532\u20132534 (1997).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57260-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57260-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T20:18:03Z","timestamp":1751746683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-57260-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["57260"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-57260-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4784403\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5817"}}